Cell-specific adenovirus vectors comprising an internal ribosome entry site

Details for Australian Patent Application No. 2001247648 (hide)

Owner Cell Genesys, Inc

Inventors Yu, De-Chao; Little, Andrew S.; Henderson, Daniel R.; Li, Yuanhao

Agent Blake Dawson Waldron

Pub. Number AU-B-2001247648

PCT Pub. Number WO01/73093

Priority 60/192,156 24.03.00 US

Filing date 21 March 2001

Wipo publication date 8 October 2001

Acceptance publication date 30 March 2006

International Classifications

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

20 March 2003 Amendment Made

  The nature of the amendment is: Amend the inventors to include Andrew S. Little

30 March 2006 Application Accepted

  Published as AU-B-2001247648

3 August 2006 Standard Patent Sealed

19 May 2011 Assignment Registered

  Cell Genesys, Inc. The patent has been assigned to Cold Genesys, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001247649

2001247647